Skip to main content

FDA Approvals

FDA Approvals
Lixisenatide Continues to Show Good Results in GetGoal Program Studies
Mary Mosley
Read More
FDA Approvals
Novel Basal Insulin LY2605541 Lowers Blood Glucose, Enhances Weight Loss
Wayne Kuznar
Read More
FDA Approvals
New Long-Acting Insulin Degludec Lowers Hypoglycemia Significantly versus Insulin Glargine
Wayne Kuznar
Read More
FDA Approvals
The Oncology Drug Pipeline Robust with Novel Agents
Caroline Helwick, Wayne Kuznar
Read More
FDA Approvals
Drugs in Phase 3 Clinical Trials for Type 2 Diabetes
Alice Goodman
Read More
FDA Approvals
Novel Approaches to Therapy in the Oncology Pipeline
Caroline Helwick
Read More
FDA Approvals, Original Research
Strategies to Prevent Opioid Misuse, Abuse, and Diversion That May Also Reduce the Associated Costs
Kathryn L. Hahn, PharmD, DAAPM, CPE
Stakeholder Perspective
Just Say No
by Atheer A. Kaddis, PharmD
Read More
FDA Approvals
Promising Oncology Drugs in the Pipeline
Caroline Helwick
Read More
FDA Approvals, Perspectives
FDA WATCH
Wayne Kuznar, Nirav R. Shah, MD,MPH, F. Randy Vogenberg, PhD, FASHP
Read More
FDA Approvals
Regulatory Concerns Fuel Hunger in Congress for FDA Reform
Mark Senak, JD
Read More
Page 51 of 53
Results 501 - 510 of 522